TH8-94549-57678 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-06-23
Dose 1 — Pfizer-BioNTech
2021-06-24
Registered in v-safe
2021-06-24
Health check-in — days 1–6 daily, dose 1, dependent
Feeling: Good · Site: Pain · None

Adult check-in
2021-06-25
Health check-in — days 1–6 daily, dose 1, dependent
Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do their normal daily activities

Adult check-in
2021-06-27
Survey response — days 1–6 daily, dose 1, dependent
MedDRA: Erythema, Feeling hot, Hyperhidrosis — Feeling: Fair · Headache · Be unable to do their normal daily activities

Free text: Complains of feeling overly hot but no fever. Has sweating and redness with the hot feeling.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-06-23	Pfizer-BioNTech	No

Free text

Release 9 — days 1–6 daily, dose 1, dependent

2021-06-27

Systemic reaction (other): Complains of feeling overly hot but no fever. Has sweating and redness with the hot feeling.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Erythema	✓	✓	✓
SRO	Feeling hot	✓	✓	✓
SRO	Hyperhidrosis	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release